BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

ProSensa Holding N.V. 

Wassenaarseweg 72

Leiden    2333 AL  The Netherlands
Phone: 31-71-5274202 Fax: 31-71-5274203


SEARCH JOBS




Industry
Biotechnology






 Company News
Analyst: First Quarter of 2015 Crucial to ProSensa Holding N.V. (RNA), BioMarin Pharmaceutical Inc. (BMRN) Deal 11/25/2014 4:37:51 PM
BioMarin Pharmaceutical Inc. (BMRN), ProSensa Holding N.V. (RNA) Marriage Makes Sense for Investors If Regulatory Hurdles Can Be Overcome 11/24/2014 1:41:33 PM
BioMarin Pharmaceutical Inc. (BMRN) Acquires ProSensa Holding N.V. (RNA) For Up To $840M; Gaining Experimental Drisapersen 11/24/2014 5:41:26 AM
ProSensa Holding N.V. (RNA) Announces 3rd Quarter 2014 Financial Results And Recent Corporate Developments 11/17/2014 12:02:47 PM
Cure Duchenne And ProSensa Holding N.V. (RNA) To Present Collaboration At Partnering For Cures Conference 11/13/2014 11:07:24 AM
Cure Duchenne And ProSensa Holding N.V. (RNA) To Present Collaboration At Partnering For Cures Conference 11/13/2014 10:35:58 AM
ProSensa Holding N.V. (RNA) To Webcast Conference Call Discussing 3rd Quarter 2014 Financial Results And Corporate Update On November 17, 2014 11/10/2014 7:48:12 AM
ProSensa Holding N.V. (RNA) To Present At Upcoming Investor Conferences 11/7/2014 10:29:12 AM
ProSensa Holding N.V. (RNA) Begins NDA Submission To The FDA For Exon-Skipping Drug Drisapersen To Treat Duchenne Muscular Dystrophy 10/13/2014 7:33:04 AM
ProSensa Holding N.V. (RNA) Begins NDA Submission To The FDA For Exon-Skipping Drug Drisapersen To Treat Duchenne Muscular Dystrophy 10/10/2014 1:47:44 PM
12345678